Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IDH3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
C5orf58 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SNORD24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDGFRP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MS4A7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC730268 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DANCR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATPIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM104B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VTI1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBRSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOLC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCAPG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METRN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on